{
  "actions": [
    {
      "acted_at": "2022-04-07",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2022-04-07",
      "action_code": "H11100",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on the Judiciary.",
      "type": "referral"
    },
    {
      "acted_at": "2022-11-01",
      "action_code": "",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr7473-117",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Judiciary",
      "committee_id": "HSJU"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Judiciary",
      "committee_id": "HSJU",
      "subcommittee": "Subcommittee on Administrative State, Regulatory Reform, and Antitrust",
      "subcommittee_id": "05"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "C001084",
      "district": "1",
      "name": "Cicilline, David N.",
      "original_cosponsor": true,
      "sponsored_at": "2022-04-07",
      "state": "RI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "D000623",
      "district": "11",
      "name": "DeSaulnier, Mark",
      "original_cosponsor": true,
      "sponsored_at": "2022-04-07",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "N000002",
      "district": "10",
      "name": "Nadler, Jerrold",
      "original_cosponsor": true,
      "sponsored_at": "2022-04-07",
      "state": "NY",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "P000618",
      "district": "45",
      "name": "Porter, Katie",
      "original_cosponsor": true,
      "sponsored_at": "2022-04-07",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "R000606",
      "district": "8",
      "name": "Raskin, Jamie",
      "original_cosponsor": true,
      "sponsored_at": "2022-04-07",
      "state": "MD",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001145",
      "district": "9",
      "name": "Schakowsky, Janice D.",
      "original_cosponsor": true,
      "sponsored_at": "2022-04-07",
      "state": "IL",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000800",
      "district": "0",
      "name": "Welch, Peter",
      "original_cosponsor": true,
      "sponsored_at": "2022-04-07",
      "state": "VT",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2022-04-07",
  "number": "7473",
  "official_title": "To prohibit pharmaceutical manufacturers from interfering with therapeutically equivalent or interchangeable substitution decisions by health care providers to limit competition from a generic drug or biosimilar biological product, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Generic Substitution Noninterference Act",
  "sponsor": {
    "bioguide_id": "M000087",
    "district": "12",
    "name": "Maloney, Carolyn B.",
    "state": "NY",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2022-04-07",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2022-04-07",
    "date": "2022-09-20T17:20:15Z",
    "text": "Generic Substitution Noninterference Act\n\nThis bill prohibits drug manufacturers from helping or directing health care providers to limit prescriptions to brand-name drugs when generic versions are available. The Federal Trade Commission and states may enforce this bill through civil actions."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Generic Substitution Noninterference Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Generic Substitution Noninterference Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To prohibit pharmaceutical manufacturers from interfering with therapeutically equivalent or interchangeable substitution decisions by health care providers to limit competition from a generic drug or biosimilar biological product, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2023-05-11T15:46:24Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr/BILLSTATUS-117hr7473.xml"
}